Chemfab Alkalis Reports Strong Q1 Performance with 178% Jump in Net Profit

1 min read     Updated on 31 Jul 2025, 09:07 PM
scanx
Reviewed by
Radhika SahaniScanX News Team
whatsapptwittershare
Overview

Chemfab Alkalis Limited has reported impressive Q1 financial results. Consolidated revenue increased by 19.61% to Rs 915.00 million, while net profit soared by 177.78% to Rs 25.00 million. EBITDA improved to Rs 113.00 million with a margin expansion to 12.35%. The company operates in Chemicals and PVC-O Pipes segments, with the latter showing stronger performance. Operational updates include new equity share allotment, amendments to employee stock options scheme, and board-level changes.

15521848

*this image is generated using AI for illustrative purposes only.

Chemfab Alkalis Limited has reported a robust financial performance for the first quarter, with significant growth in both revenue and profitability.

Financial Highlights

  • Revenue Growth: The company's consolidated revenue from operations increased to Rs 915.00 million, up from Rs 765.00 million in the corresponding quarter of the previous year, marking a 19.61% year-on-year growth.

  • Profit Surge: Consolidated net profit after tax jumped to Rs 25.00 million, compared to Rs 9.00 million in the same quarter last year, representing a substantial 177.78% increase.

  • EBITDA Performance: The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) improved to Rs 113.00 million from Rs 83.00 million year-over-year, with the EBITDA margin expanding to 12.35% from 10.85% in the same period last year.

Segment-wise Performance

Chemfab Alkalis operates in two primary segments:

  1. Chemicals and Related Products: This segment continues to be a significant contributor to the company's revenue.

  2. PVC-O Pipes: The PVC-O Pipes segment showed stronger performance compared to the Chemicals segment.

Operational Updates

  • The Board of Directors approved the allotment of 4,000 equity shares under the Chemfab Alkalis Employees Stock Options Scheme (CAESOS 2020).
  • The company amended the CAESOS 2020 scheme, subject to shareholder approval, increasing the total number of options from 4,00,000 to 5,00,000.
  • Mr. C. S. Ramesh resigned as Non-Executive and Non-Independent Director, effective July 31.
  • The Board reconstituted various committees, including the Audit Committee, Nomination and Remuneration Committee, CSR Committee, and Stakeholders Relationship Committee.

Standalone Performance

On a standalone basis, Chemfab Alkalis reported:

  • Net profit of Rs 539.40 lakhs, compared to Rs 393.06 lakhs in the previous quarter and Rs 332.89 lakhs in the same quarter last year.
  • Revenue from operations stood at Rs 8,758.10 lakhs versus Rs 8,784.59 lakhs in the preceding quarter.

Outlook

While the company has not provided specific forward-looking statements, the strong Q1 performance sets a positive tone for the fiscal year. The expansion in EBITDA margin suggests improved operational efficiency, which could bode well for future quarters if market conditions remain favorable.

Chemfab Alkalis Limited continues to demonstrate its resilience and adaptability in a dynamic market environment, positioning itself for potential growth opportunities in both its core chemical business and the expanding PVC-O pipes segment.

Historical Stock Returns for Chemfab Alkalis

1 Day5 Days1 Month6 Months1 Year5 Years
-0.05%-2.91%-6.90%-14.32%-37.64%+373.90%
Chemfab Alkalis
View in Depthredirect
like15
dislike

Chemfab Alkalis Reports Mixed Q4 Results: EBITDA Up, Net Loss Widens

2 min read     Updated on 14 May 2025, 08:26 PM
scanx
Reviewed by
ScanX News Team
whatsapptwittershare
Overview

Chemfab Alkalis' Q4 FY2024 results show revenue growth of 12.15% to ₹923.00 crore and EBITDA increase of 8.13% to ₹133.00 crore. However, the company's net loss widened by 70.37% to ₹92.00 crore, compared to ₹54.00 crore in Q4 FY2023. EBITDA margin slightly decreased to 14.45% from 14.97% year-over-year.

8780179

*this image is generated using AI for illustrative purposes only.

Chemfab Alkalis , a leading manufacturer of chlor-alkali products, has released its financial results for the fourth quarter of the fiscal year. The company's performance shows a mixed picture, with improvements in some areas and challenges in others.

Revenue Growth and EBITDA Improvement

Chemfab Alkalis reported a notable increase in revenue for Q4, rising to ₹923.00 crore from ₹823.00 crore in the same quarter last year, marking a 12.15% year-over-year growth. This growth in revenue reflects the company's ability to expand its market presence and potentially increase its sales volume.

The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) also saw an improvement, increasing to ₹133.00 crore from ₹123.00 crore in the previous year, representing an 8.13% rise. This growth in EBITDA indicates better operational efficiency and cost management by the company.

Margin Pressure and Net Loss

Despite the growth in revenue and EBITDA, Chemfab Alkalis faced some challenges in its profitability metrics. The EBITDA margin slightly decreased to 14.45% from 14.97% year-over-year, suggesting some pressure on the company's pricing power or increased input costs.

More significantly, the company reported a consolidated net loss of ₹92.00 crore for the quarter, compared to a loss of ₹54.00 crore in the same period last year. This widening of losses by 70.37% is a concern for investors and indicates that the company is facing challenges in translating its revenue growth into bottom-line profitability.

Financial Performance Overview

To provide a clearer picture of Chemfab Alkalis' financial performance, here's a summary of key metrics for the quarter:

Metric Q4 FY2024 Q4 FY2023 YoY Change
Revenue ₹923.00 crore ₹823.00 crore +12.15%
EBITDA ₹133.00 crore ₹123.00 crore +8.13%
EBITDA Margin 14.45% 14.97% -52 bps
Net Loss ₹92.00 crore ₹54.00 crore +70.37%

Outlook and Challenges

While Chemfab Alkalis has demonstrated its ability to grow revenue and improve operational efficiency, the widening net loss presents a significant challenge. The company may need to focus on cost reduction strategies, improving its product mix, or exploring new market opportunities to reverse the trend of increasing losses.

The slight decrease in EBITDA margin also suggests that the company might be facing competitive pressures or increased costs in its operations. Management's ability to address these challenges will be crucial for the company's future financial health and performance.

Investors and analysts will be closely watching Chemfab Alkalis' future quarterly results to see if the company can translate its revenue growth into improved bottom-line performance and return to profitability.

Historical Stock Returns for Chemfab Alkalis

1 Day5 Days1 Month6 Months1 Year5 Years
-0.05%-2.91%-6.90%-14.32%-37.64%+373.90%
Chemfab Alkalis
View in Depthredirect
like15
dislike
Explore Other Articles
640.00
-0.35
(-0.05%)